A $46 million series B financing is expected to help Reflexion Medical Inc. commercialize its biology-guided radiotherapy system, which is designed to use a tumor's own signal to deliver radiation.
U.S. surgeons will now have access to an online 3-D planning software that could help them personalize spine surgery based on stereo-radiographic imaging data obtained in the functional standing position.
Flexibility is the key differentiator of Atricure Inc.'s newest FDA-cleared device. The company launched the Cryoform cryoablation probe in Europe last year under a CE mark and now has an FDA 510(k) clearance for the U.S. market.
The hype surrounding renal denervation (RDN) came crashing down in early 2014 after the failed SYMPLICITY HTN-3 trial sidelined front-runner Medtronic plc and spooked several of its smaller challengers, at least where the U.S. market was concerned. Then, last year, Dublin-based Medtronic revived hope for the RDN field by re-launching a revised version of its clinical program for the technology.
